ProFem is a pharmaceutical company with a focus on the clinical development of drugs for the treatment of gynecological diseases. Its main focus lies on infections of the lower urogenital tract, diseases that are frequently associated with the growth of so-called biofilms. ProFem's lead product is Candiplus, a medicine for the topical treatment of chronic vulvovaginal candidiasis.